Avior Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-33
| Closed | -$7.77K | – | 792 |
|
|
2024
Q4 | $7.77K | Buy |
33
+28
| +560% | +$6.59K | ﹤0.01% | 1705 |
|
|
2024
Q3 | $1.38K | Sell |
5
-4
| -44% | -$1.1K | ﹤0.01% | 2036 |
|
|
2024
Q2 | $2.19K | Hold |
9
| – | – | ﹤0.01% | 1927 |
|
|
2024
Q1 | $1.35K | Buy |
+9
| New | +$1.35K | ﹤0.01% | 2341 |
|
|
2020
Q2 | – | Sell |
-1,420
| Closed | -$154K | – | 888 |
|
|
2020
Q1 | $154K | Sell |
1,420
-1,070
| -43% | -$116K | 0.03% | 378 |
|
|
2019
Q4 | $286K | Sell |
2,490
-390
| -14% | -$44.8K | 0.05% | 331 |
|
|
2019
Q3 | $231K | Sell |
2,880
-1,560
| -35% | -$125K | 0.04% | 346 |
|
|
2019
Q2 | $322K | Buy |
4,440
+1,380
| +45% | +$100K | 0.06% | 280 |
|
|
2019
Q1 | $285K | Buy |
3,060
+1,330
| +77% | +$124K | 0.06% | 284 |
|
|
2018
Q4 | $126K | Buy |
1,730
+650
| +60% | +$47.3K | 0.03% | 401 |
|
|
2018
Q3 | $95K | Sell |
1,080
-310
| -22% | -$27.3K | 0.02% | 440 |
|
|
2018
Q2 | $137K | Buy |
+1,390
| New | +$137K | 0.03% | 412 |
|